Search for: "THE MEDICINES COMPANY v. HOSPIRA, INC. "
Results 21 - 33
of 33
Sorted by Relevance
|
Sort by Date
13 Jul 2016, 4:21 pm
§ 102(b) (pre-AIA).[1] The en banc opinion in The Medicines Company v. [read post]
9 Feb 2015, 1:15 am
Now, Darren sinks his paws on the appeal decision in Hospira (UK) Ltd v Genentech, Inc [2015] EWCA Civ 57 (6 February 2015). [read post]
2 Dec 2009, 4:31 am
Because other countries just decide to pay less – Pfizer’s patent battle against UniLab (Patent Baristas) Moxifloxacin – Venezuela annuls two of Bayer’s patents relating to Moxifloxacin (IP tango) (IP tango) Plavix (Clopidogrel) – India: Indian company, Cadila, bears the brunt of section 3(d) (Spicy IP) Sanctura (Trospium) – US: Allergan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Taxotere (Docetaxel)… [read post]
24 Oct 2012, 3:51 pm
On October 23, 2012, K-V Pharmaceutical Company of St. [read post]
9 Dec 2009, 3:59 pm
Teva Parenteral Medicines, Inc. et al. [read post]
31 Aug 2010, 10:01 pm
– state of research and development of new drugs in Indian pharma industry (Spicy IP) US: The Financial Times’ take on gene patenting (Patent Docs) US: Seattle Biotech companies fight over allegedly similar names: Mirina Corp. v. [read post]
22 Apr 2010, 3:51 am
Paddock Laboratories, Inc. [read post]
16 Feb 2015, 1:44 am
| Hospira v Genetech Mark 1, the Appeal| Litigation-Proof Patents: Avoiding the Most Common Patent Mistakes and Patent Portfolios: Quality, Creation, and Cost reviewed | Italy and San Marino’s friendship on IP is over| Problems and imperfections in biotech patenting: realities on the ground and trying to fix the system. [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes… [read post]
7 Feb 2022, 10:32 am
Hospira, Inc., the Eleventh Circuit extended the POM Wonderful rule to Lanham Act claims concerning drug labels. 1 F.4th 1374, 1380–81 (11th Cir. 2021). [read post]
17 Mar 2020, 1:32 pm
Understanding FDA Recalls of Drugs and Medical Devices An FDA recall of a drug or medical device is the often voluntary action of a company to correct and/or remove a medicine or product from public circulation because it’s in violation of the laws and regulations that the FDA is charged with enforcing. [read post]
11 Aug 2017, 9:09 am
In 1946, in Metallizing Eng’g Co. v. [read post]
9 Aug 2008, 1:50 am
: (Patenting Lives), Worldwide increase in patent filings puts strain on system: (Managing Intellectual Property), WIPO releases 2008 Worldwide Patent Report: (Peter Zura's 271 Patent Blog), (Patent Prospector), (IP Updates), Global patent filings continue rise but may level off; smaller nationals slipping: (Intellectual Property Watch), Means plus function: Don’t ignore the man behind the curtain: (Intellectual Property Directions), Technology start-up entrepreneurs and CEOs: If your… [read post]
